Live Breaking News & Updates on Immune Monitoring Facility

Stay updated with breaking news from Immune monitoring facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Borghaei on Determining Treatments Utilizing Biomarker Testing in NSCLC

Hossein Borghaei, DO, MS, discusses the importance of determining the most suitable treatment for patients with non–small cell lung cancer through the use of biomarker testing.
....

Edmundm Dunn , Hossein Borghaei , Department Of Hematology Oncology , Division Of Thoracic Medical Oncology , Fox Chase Cancer Center At Temple Health , Thoracic Medical Oncology , Immune Monitoring Facility , Thoracic Oncology , Fox Chase Cancer Center , Temple Health , Per New York Lung Cancer Symposium , Lung Cancer ,

IO Combos Yield OS Advantage Vs Chemo Alone in Stage IV PD-L1–Negative NSCLC

As treatments for patients with stage IV non–small cell lung cancer continue to evolve, patients with PD-L1–negative disease represent a unique cohort and chemotherapy/immunotherapy or immunotherapy doublet regimens appear to be effective. ....

United States , Fox Chase , University Of Pennsylvania , New York , Edmundm Dunn , Hossein Borghaei , Merck Celgene , Department Of Hematology Oncology , Cart Program , Thoracic Oncology At Fox Chase Cancer Center , Division Of Thoracic Medical Oncology , Safety Monitoring Board For University Of Pennsylvania , Boehringer Ingelheim , Annual New York Lung Cancers Symposium , Thoracic Medical Oncology , Immune Monitoring Facility , Thoracic Oncology , Fox Chase Cancer Center , World Data , Advisory Board , Scientific Advisory Board , Stock Options , Safety Monitoring Board ,